INTERPACE BIOSCIENCES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $542.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2022-11-14
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2022-09-30 was $178.00K, a 23.61% increase year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2022-06-30 was $205.00K, a 51.85% increase year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2022-03-31 was $159.00K, a 33.61% increase year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2021-12-31 was -$393.00K, a 266.53% decline year-over-year.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2021 was $5.00K, a 99.32% decline from fiscal 2020.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2020 was $737.00K, a 16.98% increase from fiscal 2019.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2019 was $630.00K, a 105.21% increase from fiscal 2018.
- INTERPACE BIOSCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2018 was $307.00K, a 18.08% increase from fiscal 2017.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|---|
| 2022-09-30 | $178.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $383.00K derived: sum of 2 quarters · filed 2022-11-14 | $542.00K 10-Q · filed 2022-11-14 | $149.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $364.00K 10-Q · filed 2022-08-15 | -$29.00K derived: sum of 3 quarters · filed 2022-08-15 | $115.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | $159.00K 10-Q · filed 2022-05-16 | -$234.00K derived: sum of 2 quarters · filed 2022-05-16 | -$90.00K derived: sum of 3 quarters · filed 2022-05-16 | $45.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | -$393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$249.00K derived: sum of 2 quarters · filed 2022-03-31 | -$114.00K derived: sum of 3 quarters · filed 2022-03-31 | $5.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $279.00K derived: sum of 2 quarters · filed 2021-11-10 | $398.00K 10-Q · filed 2021-11-10 | $634.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $254.00K 10-Q · filed 2021-08-11 | $490.00K derived: sum of 3 quarters · filed 2021-08-11 | $683.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | $119.00K 10-Q · filed 2021-05-11 | $355.00K derived: sum of 2 quarters · filed 2021-05-11 | $548.00K derived: sum of 3 quarters · filed 2021-05-11 | $720.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-01 | $429.00K derived: sum of 2 quarters · filed 2021-04-01 | $601.00K derived: sum of 3 quarters · filed 2021-04-01 | $737.00K 10-K · filed 2021-04-01 |
| 2020-09-30 | $193.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-01-20 | $365.00K derived: sum of 2 quarters · filed 2021-01-20 | $501.00K 10-Q · filed 2021-01-20 | $697.00K derived: sum of 4 quarters · filed 2021-01-20 |
| 2020-06-30 | $172.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2021-01-19 | $308.00K 10-Q/A · filed 2021-01-19 | $504.00K derived: sum of 3 quarters · filed 2021-01-19 | $675.00K derived: sum of 4 quarters · filed 2021-01-19 |
| 2020-03-31 | $136.00K 10-Q/A · filed 2021-01-19 | $332.00K derived: sum of 2 quarters · filed 2021-01-19 | $503.00K derived: sum of 3 quarters · filed 2021-01-19 | $646.00K derived: sum of 4 quarters · filed 2021-01-19 |
| 2019-12-31 | $196.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-01-19 | $367.00K derived: sum of 2 quarters · filed 2021-01-19 | $510.00K derived: sum of 3 quarters · filed 2021-01-19 | $630.00K 10-K/A · filed 2021-01-19 |
| 2019-09-30 | $171.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $314.00K derived: sum of 2 quarters · filed 2019-11-14 | $434.00K 10-Q · filed 2019-11-14 | $509.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $263.00K 10-Q · filed 2019-08-13 | $338.00K derived: sum of 3 quarters · filed 2019-08-13 | $415.00K derived: sum of 4 quarters · filed 2019-08-13 |
| 2019-03-31 | $120.00K 10-Q · filed 2019-05-14 | $195.00K derived: sum of 2 quarters · filed 2019-05-14 | $272.00K derived: sum of 3 quarters · filed 2019-05-14 | $350.00K derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-21 | $152.00K derived: sum of 2 quarters · filed 2019-03-21 | $230.00K derived: sum of 3 quarters · filed 2019-03-21 | $307.00K 10-K · filed 2019-03-21 |
| 2018-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $155.00K derived: sum of 2 quarters · filed 2018-11-14 | $232.00K 10-Q · filed 2018-11-14 | $232.00K derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $155.00K 10-Q · filed 2018-08-09 | $155.00K derived: sum of 3 quarters · filed 2018-08-09 | $390.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | $77.00K 10-Q · filed 2018-05-15 | $77.00K derived: sum of 2 quarters · filed 2018-05-15 | $312.00K derived: sum of 3 quarters · filed 2018-05-15 | $312.00K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $235.00K derived: sum of 2 quarters · filed 2018-03-23 | $235.00K derived: sum of 3 quarters · filed 2018-03-23 | $260.00K 10-K · filed 2018-03-23 |
| 2017-09-30 | $235.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $235.00K derived: sum of 2 quarters · filed 2017-11-13 | $260.00K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $25.00K 10-Q · filed 2017-08-10 | ||
| 2017-03-31 | $25.00K 10-Q · filed 2017-05-12 |